Courtesy of Mercedes-Benz/Bosch
Mercedes-Benz Offers a Glimpse Into a Future Where Your Car Parks Itself
Sign up for dot.LA's daily newsletterfor the latest news on Southern California's tech, startup and venture capital scene.
Angelenos famously hate parking, but soon their cars may be able to park themselves thanks to a collaboration between Mercedes-Benz and German engineering firm Bosch.
At a demonstration in Downtown Los Angeles on Wednesday, Mercedes and Bosch gave the first U.S. test run showcasing the fruits of their collaboration: an electric Mercedes-Benz 2022 EQS 580 luxury sedan capable of navigating itself into a parking spot.
Painted in bright teal stripes, the sedan first let its driver out at a designated spot. Then, a tap of a Mercedes-Benz phone app locked the vehicle and sent it, at a gradual pace, to the first available parking space. Later, a ping from the app woke up the car—which turned itself on, pulled out of the parking spot and slowly made its way to the driver’s pickup point.
Painted in bright teal stripes, an electric Mercedes-Benz 2022 EQS 580 pulls into a parking spot with no driver.Courtesy of Mercedes-Benz/Bosch
A Bosch engineer stepped in front of the car several times as it was driving to demonstrate its safety features; if sensors detect a presence or any motion in front of the car, they’ll tell it to stop a safe distance away. (For extra security, a person walked alongside the car with an emergency shut-off button.)
Kay Stepper, Bosch’s senior vice president of automated driving for North America, noted that the self-parking technology relies on sensors and cameras built into its surrounding environment, which guide the car into its space. (The sensors are installed on the ground, while the cameras are mounted above.) He added that the technology could be applied to any type of car, so long as a manufacturer makes it compatible with its vehicle.
“The unique thing is really that we are not using any of the in-vehicle sensors—it’s a purely infrastructure-based solution,” Stepper told dot.LA.
Courtesy of Mercedes-Benz/Bosch
The vehicle pulls out from its parking spot and drives itself to its owner.
The demo marked the first time that Mercedes and Bosch have tested the technology outside of Germany. In their home country, the driverless parking capability is already installed and ready to use at Stuttgart Airport pending final regulatory approval, according to Philipp Skogstad, Mercedes’ president and CEO of North American research and development.
A handful of other auto industry names are also investing in automated valets, including the Volkswagen Group-owned CARIAD, which demonstrated its technology at an industry summit in Munich last. Yet another competitor is Maryland-based STEER. Other companies focused on autonomous technology from more of a road-driving perspective are Google’s Waymo and, of course, Tesla.
Skogstad acknowledged the increasingly crowded playing field. “Automated driving is such a complex task requiring so many pieces to come together that nobody can do that alone,” he said. “No matter how much money you have, you need partners.”
A Bosch engineer tests the self-parking car’s pick-up options.Courtesy of Mercedes-Benz/Bosch
Stepper noted that Bosch is “intensely” focused on finding collaborators in the “smart infrastructure” space who can help it implement a driverless parking network. The next step, he added, is to convince local parking operators to invest in the technology. Without human error (consider that driver in your apartment building’s garage who’s always double-parked), he estimated that a fully-automated parking lot could fit up to 20% more cars.
And what about the valet workers—such as those on hand at the demo, who were kind enough to park cars for the event’s attendees the old-fashioned way? A Bosch spokesperson noted that they wouldn’t exactly be put out of business, as self-parking garages would still need humans to operate and maintain their technology and act as a safeguard.
From Your Site Articles
- Autonomous Vehicle Companies Doubled Their Testing Miles - dot.LA ›
- Motional Expands Its Autonomous Vehicle Operations in LA - dot.LA ›
Related Articles Around the Web
Subscribe to our newsletter to catch every headline.
Photo: VETS
At first, Marcus was skeptical. But after having spent nearly seven years taking various antidepressants, sleeping pills, and focus medications, Marcus was out of options.
“He had nothing to lose,” Amber says. So they decided to check Marcus into a treatment center in Mexico for a “heroic dose” of Ibogaine, an anti-addiction compound found in a West African plant that indigenous peoples have used for years as a form of psychedelic therapy. Marcus followed his first Ibogaine treatment with DMT.
Commonly known as the “spirit molecule,” DMT is considered one of the most powerful psychedelics in existence and researchers are just beginning to document its potential benefits in treating an array of mental health ailments including PTSD and addiction.
“I felt the weight of the world on my shoulders, was super anxious and I was really depressed,” Marcus says. “I just came out of there feeling extremely light,” as though he’d condensed “ten years of talk therapy” into a single week.
In 2019, two years after Marcus’s initial brush with psychedelic therapy, he decided to form VETS (Veterans Exploring Treatment Solutions), a San Diego-based nonprofit that offers veterans grants to pursue psychedelic therapy outside the U.S. Amber serves as the nonprofit’s executive director while Marcus is its chairman.
Marcus Capone and wife Amber after he completed BUD/S training. Photo: VETS
Currently, 17 veterans die by suicide every day, 57% more than civilians in the same age range, according to a study released by the VA in September. According to the department, over 1.7 million veterans were treated for mental health problems last year.
“While VA is conducting initial studies of the effectiveness of psychedelic drugs as a form of treatment for veterans with PTSD and other serious mental health issues, it’s important to note that there is much more to learn at this time,” a spokesperson for the VA tells dot.LA. “We do not endorse or encourage the use of any psychoactive substances as part of a self-treatment program.”
VETS co-founder and Chairman Marcus Capone.
Photo: VETS
The agency also says that while it “must follow all federal laws regarding Schedule I drugs,” and that “VA health care providers may not recommend them or assist veterans to obtain them, ” veterans who choose to take or are taking illegal drugs, won’t be denied their VA benefits.
Since its launch two years ago VETS has raised $7 million and helped over 700 veterans seek treatment in Mexico and Costa Rica.
“The Navy SEAL community, we do probably one of the best jobs in the world at taking care of each other,” Marcus says. “We pick up the slack if we’re not getting the support that we need. It's always been that way.” Adding that our country has a bad track record of taking care of its veterans when they return home – “I went and did work with the Israeli SEALs and they said, ‘you guys are like the world's premier fighting force [and] your country sucks at taking care of you when you come back.”
There are some signs that these unconventional therapies could become more mainstream. In July Democratic Sen. Cory Booker and Republican Sen. Rand Paul introduced a bill that would grant terminally ill people access to therapies that are currently classified as schedule I drugs. Texas Republican Sen. Dan Crenshaw and New York Democrat Alexandria Ocasio-Cortez co-sponsored an amendment to the National Defense Authorization Act that instructed the Pentagon to conduct more research on psychedelics and passed in July. But currently the only psychedelic that can be legally prescribed in the U.S. is ketamine.
“This is an issue that seems to be very bipartisan, very purple, and [it’s] very exciting,” says Amber. “It's really encouraging to see our nation's leaders actually agree on something and not only just agree on it, but actually come out together in support of it.”
